A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

Parag Jitendra Parikh, Percy Lee, Daniel A. Low, Joshua Kim, Kathryn E. Mittauer, Michael F. Bassetti, Carri K. Glide-Hurst, Ann C. Raldow, Yingli Yang, Lorraine Portelance, Kyle R. Padgett, Bassem Zaki, Rongxiao Zhang, Hyun Kim, Lauren E. Henke, Alex T. Price, Joseph D. Mancias, Christopher L. Williams, John Ng, Ryan PennellM. Raphael Pfeffer, Daphne Levin, Adam C. Mueller, Karen E. Mooney, Patrick Kelly, Amish P. Shah, Luca Boldrini, Lorenzo Placidi, Martin Fuss, Michael D. Chuong

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences